Welcome to Seacross Pharmaceuticals Ltd.
PlantProfile
Capacity


  • Two MHRA approved lines for injectables that are scalable on demand.
  • Up to 30 million units annually with potential upgrade.
  • New workshops under construction, including oral solid, pre-filled syringe, powder filling injectable.


Workshop I (Oncology Injectable)

  • Compounding, filling 2ml-100ml (liquid & lyophilization) oncology injectable.
  • Up to 300 L compounding volume, 300vial/min,14 sq.m lyophilizer expandable to 42 sq.m
  • Integrated 0~2ºC aseptic filling process from compounding to lyophilization.


Workshop M (Non-oncology Injectable) 

  • Compounding, filling 2ml-100ml (liquid) non-oncology injectable.
  • Up to 300 L compounding volume,120 vial/min.


Workshop P 

  • Visual inspection & packaging line.
  • Innovative protective sheathing available, minimizing the risk of exposure of healthcare professionals.


© Copyright - Clinico fusce blandit sapien eu